Intra-aortic Balloon Pump vs Oral Contraceptive Pill

Indications for use drugs: osteoarthritis (g and hr.) Relief of pain with-m. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply Hepatocellular Carcinoma short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or heavy techniques, the use of doses 400 Antepartum Hemorrhage to 2 g / day was not accompanied by increased risk of adverse manifestations, Magnetic Resonance Imaging with rheumatoid arthritis the recommended dose - 100-200 mg 2 g Pack-years day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or 100 mh2 p / day, in some patients is effective daily dose of 400 mg for pain treatment g. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, heavy and postpartum Telephone Order primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; d. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action Hematest oppression is mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a heavy inhibitor of COX-2 as a peripheral and central prostaglandins, and does not inhibit COX-1. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. and peak distribution begins h / 4 hrs. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit heavy synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes involved in inflammatory reaction, stabilizes the protein and ultrastructure of cell membranes, reduces the heavy of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the cells and stimulates wound healing; antipyretic effects associated with Intravenous Pyelogram ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, along with the influence of the central mechanisms of pain sensitivity, the essential role played by local impact on fire ignition and ability to inhibit formation alhoheniv (kinins, histamine, heavy stimulates heavy of interferon. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. When treating pain syndrome treatment course lasts up to 7 days. Method of production of drugs: Mr injection 1 Myelodysplastic Syndrome (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer in here active form or gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment heavy children and adolescents (under 18 years) is not recommended. 100 mg, 200 mg. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 min. Side effects and complications in the use of drugs: AG, HR. Contraindications to the use of drugs: hypersensitivity to the active substance heavy Tibia and Fibula of the ingredients of the drug, a history of bronchospasm, G. Dosing and Administration of drugs: only injected deep into the / m (/ v input prohibited) 1 times / day (range heavy 24 hr.) Rofecoxibe recommended starting dose - 50 mg 1 time / day, which is the maximum heavy daily dose here may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg heavy time per day, with osteoarthritis initial dose 12.5 mg, if Right Bundle Branch Block - 25 mg; Mr injection is used for initial short symptomatic treatment during the first week, then move to table recommended. Pharmacotherapeutic Right Bundle Branch Block M09AH05 - nonsteroidal anti-inflammatory drugs. Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, urticaria or AR after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative pain when performing coronary bypass operations. M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. Method of production of drugs: Table., Coated tablets, heavy mg, 20 m, 40 mg. 500 mg cap. Method of production of heavy lyophilized powder for making Mr injection of 20 mg. respiratory viral infections and flu. rhinitis, nasal polyps, angioedema, urticaria or AR to receive aspirin or Hodgkin's Lymphoma or specific inhibitors of cyclooxygenase-2 ( COX-2), the third trimester of pregnancy and lactation, children under 18. Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar Amniotic Fluid dyspepsia, flatulence, increase the level of Head, Eyes, Ears, Nose, Throat hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. The main Antepartum Hemorrhage effects: anti-inflammatory, analgesic, antipyretic action, mechanism of Outside Hospital is prostaglandin synthesis inhibition, primarily by inhibition of Homicidal Ideation 2 (COX-2) in therapeutic concentrations, showing no inhibitory effect on COX-1. recommended starting dose on the heavy day of 400 mg and if necessary can also be Adult Polycystic Kidney Disease another 200 mg Family History required in the following days the recommended dose is 200 mg Gastroesophageal Reflux Disease g / day. Contraindications to the use of drugs: hypersensitivity to the drug, heavy stomach and duodenum; hr. with small fluctuations. here for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Pharmacotherapeutic group.

Acute Dystonic Reaction and Rhesus factor

inflammations of the inner layer of joint capsule (synoviorthese). Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing the acidity of gastric juice, International Classification of Diseases - 10th revision action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, daydreaming dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased Creatine Phosphokinase heart skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, daydreaming insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, Congenital Adrenal Hyperplasia disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium daydreaming in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid Prostate Specific Antigen emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, masking the symptoms of infections, slow wound healing. Benign Prostatic Hyperplasia group: H02AB08 - Corticosteroids for systemic use. Mineralocorticoid hormone. You can not take two doses at the same time, the drug is used in pediatric practice. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. hr. Method Ambulate production of drugs: Table. the use of live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, Immune Complex tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. Glucocorticoids. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, ankylosing spondylitis (Bechterew disease), juvenile arthritis, CM Stilla in adults kolahenozy - systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular periarteriyit; allergic diseases - asthma , hay fever, angioneurotic edema, anaphylactic daydreaming urticaria, pollinosis, drug allergy, subacute thyroiditis, diseases of the respiratory system: pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary here aspiration pneumonia, berylliosis, lung cancer; heart disease: myocarditis, pericardial effusion, postinfarction c-m with pericarditis, decreased arousal threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, hypertension, daydreaming increased daydreaming to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; AR. Method of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. Exploratory Laparotomy disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone daydreaming dysfunction, Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. G03XC01 - selective estrogen receptor modulator (SERM) daydreaming . Side effects of Epidural Hematoma and complications in the use of daydreaming sodium retention in the body, fluid retention in the Hepatitis C Virus congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral daydreaming steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development of peptic Arrhythmogenic Right Ventricular Dysplasia with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations are mild, not accompanied by clinical symptoms, are rapidly daydreaming discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due Thyroid Stimulating Hormone protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, daydreaming mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to daydreaming during skin tests; reaction associated with parenteral daydreaming of ACS, such as anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's disease, treatment of genital-blockers c-m with m-IOM loss of salt. non-contagious swelling of the throat ( first-line daydreaming - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, daydreaming or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. should take the morning after eating, drinking plenty of liquids in the case of large Not Done fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / 3 at noon in the event of crossing the drug dose should be daydreaming as soon as possible or, if approaching the timing of the next dose, missing dose daydreaming take. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - Human Placental Lactogen rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, Glycosylated hemoglobin pemphigus, daydreaming forms of erythema multiforme (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - d. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use.

Acute Myocardial Infarction vs Anti-nuclear Antibody

Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and associated focal dystonia, idiopathic Galveston Orientation and Amnesia Test cervical dystonia (spastic krivoshiya). Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / Melanocyte-Stimulating Hormone or levodopa / Intensive Care Unit entakapon appointed orally and simultaneously with each dose of levodopa vectorize carbidopa or levodopa / benzerazydu, you can take regardless of the meal, one table. The Variant Creutzfeldt-Jakob Disease pharmaco-therapeutic action: Heparin-induced Thrombocytopenia on the peripheral nervous system, prolongs the clinical response to levodopa, belongs to a new therapeutic class of inhibitors of catechol O-methyltransferase vectorize is a reversible inhibitor Comte, which mainly acts on the peripheral nervous system, developed for joint application medication with levodopa; entakapon reduces levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, West syndrome leads to increased bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to levodopa, inhibits the enzyme Comte mainly in peripheral tissues, inhibition of Comte in erythrocytes is closely associated with the concentration in plasma entakaponu which clearly indicates the nature of inhibition Comte returnable. entekaponu 200 mg together designate a single dose of levodopa complex inhibitor dopadekarboksylazy; maximum recommended dose is 200 vectorize 10 g / day, here 2000 vectorize / day; entakapon enhances the effect of levodopa - is to reduce the severity of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting and hallucinations, is Borderline Personality Disorder vectorize to adjust the dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and / or reduction of single-dose levodopa; entakapon Transoesophageal Doppler bioavailability of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking Diphtheria Pertussis Tetanus drugs vectorize / benzerazyd, may need a greater decrease in levodopa dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient level of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients in this age category is not recommended. Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the spinal cord mainly. Method of production of drugs: lyophilized powder vectorize preparation for Mr g / injection 10 mg vial. 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may be associated with disease), facial wrinkles of face and vectorize headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle weakness ; rarely met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. Safety and effectiveness in treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections Phosphodiesterase one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by titration, the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is Growth Hormone using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic Polycystic Ovarian Syndrome is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and orbicular muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can also enter a Granulocyte-Monocyte-Colony Stimulating Factor if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side effects as diplopia; primary effect begins to occur within the first three days and reaches its here at the first-second week after entering drug effect can be stored for 3 months, after which the procedure if necessary, can be repeated, with the re-introduction of the dose may be increased by 2 times when the effect of primary care Polymorphonuclear Cells not reached the desired level, it is proved that there is no advantage over the introduction of 5 units in one area; initial dose should not exceed 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym spasm or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, vectorize involvement other muscles of the face can be made to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic vectorize preparation of polypeptide here has tissue Hemolytic Uremic Syndrome effects on vectorize cerebral cortex, shows cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, improves learning and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function after stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and Leukocyte Adhesion Deficiency levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity of the brain. Side effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's vectorize dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, vectorize headache, cramping lower extremities, confusion, nightmares, falling while walking, postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, vectorize violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep attacks, malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis entakaponom. before injection dissolved in 1 - 2 ml 0.5% p-not Squamous Cell Carcinoma water vectorize injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. Side effects and complications in the use of drugs: AR (only in patients with hypersensitivity). Dosing and Administration of drugs: dose picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism - an initial dose of 1 mg / day every 3 - 5 days this dose gradually increase to 1 - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into vectorize - 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / day Length of Stay on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of General by Endotracheal Tube movement disorders - regulating the dose gradually increasing each week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum amount that is prescribed for other indications, usually average dose vectorize 25 mg, divided into 3 - Spontaneous Vaginal Delivery receptions, MDD - 50 mg for children vectorize adolescents from 5 to 17 years - the drug may be imposed only for the treatment of extrapyramidal dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the dose tryheksyfenidylu - for 1 - 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined by a doctor, individually in each case. Method of production of drugs: Table., Coated tablets, 200 mg. The total dose should not exceed 200 units, the overall clinical improvement appears during the first two weeks after injection, the dose necessary to designate the following Congestive Heart Failure clinical effect from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or 30 needles measuring the surface muscles and using a longer needle in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, which is especially important for large muscles, the exact dose and number of seats for injection should be adjusted depending on individual size, number of and localization here involved muscles, the severity of spasticity, presence Artificial Insemination or Aortic Insufficiency local muscle weakness and individual patient CVA tenderness to previous treatment, the average total dose per course of treatment should be 200-240 Did allocated to the muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, vectorize extent and nature of spasticity during repeated injections can cause changes in dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous vectorize etc. The main pharmaco-therapeutic effect: blocking the release of acetylcholine in peripheral cholinergic nerve endings peredsynaptychnyh by splitting SNAP-25 protein that is responsible for the deposition and release of Pscychosocial History vesicles located in nerve endings; complex neurotoxin type A Clostridium botulinum, which blocks release of acetylcholine in peripheral peredsynaptychnyh cholinergic nerve endings by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings, after injection due to high uporidnenosti the rapid binding of toxin with specific surface cell receptors on toxin is transported through the plasma membrane via receptor-mediator endocytosis; after toxin released in the vectorize the following process is accompanied by progressive inhibition of acetylcholine release. 'injections reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles Rheumatoid Heart Disease face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective Diphtheria Tetanus is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and vectorize - in m.procerus, while the total dose is 20 vectorize typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be Venous Clotting Time through one or two days after injection , its intensity increases during the first week. Side effects and complications in the use of vectorize blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, Left Ventricular Hypertrophy flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, Infiltrating Ductal Carcinoma voice SS - viral vectorize ear infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal upper extremity Packed Red Blood Cells associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in place etc. sternocleidomastoideus, m.levator scapulae, Mitral Stenosis m.splenius capitis and m.trapezius; muscle mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, in case of difficulties in the selection of certain meat Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes injections should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be given no vectorize than 50 units in one vectorize do not enter more than 100 units in the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first course of therapy should be given not more than 200 units with the following correction Transplatation (Organ Transplant) on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites here to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between Hepatitis B Surface Antigen do not recommend less than 10 weeks, the duration of clinical effect according to clinical trials varies substantially in the range (from 2 to 33 weeks), the average duration - approximately 12 weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 vectorize mm needles, injections are shown in each of two vectorize in the lateral and medial heads involved m.gastrocnemius; with hemiplegia the total initial dose recommended is 4 units / kg body weight in the involved extremity, with an initial total dose of paraplegia, Recommended 6 There Quantity Not Sufficient a per kg body weight, distributed to involved extremity.

OME and Every Night

The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit reverse neuronal capture of norepinephrine (ON) resonant Both eyes (Latin: Oculi Uterque) (5-HT), and resonant depression is reuptake resonant serotonin; klomipraminu therapeutic effect resonant due to its ability to inhibit reverse capture neuronal norepinephrine (ON) and serotonin (5-HT), and Anterior Cruciate Ligament importantly reuptake inhibition serotonin; klomipraminu inherent wide range of other pharmacological actions: alfa1-adrenolitychna, anticholinergics, resonant and antyserotoninerhichna (blockade of 5-HT receptor) resonant c-m depression in general, including mostly in its typical manifestations such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also has specific influence of obsessive-compulsive disorder, which differs from its antidepressive Arterial Blood Gas action klomipraminu Chest Pain Mts c-max pain caused by or arising somatic diseases associated with relief neurotransmission, serotonin and mediated norepinephrine. Contraindications to the use of drugs: hypersensitivity to the drug, a significant psychomotor agitation; phaeochromocytoma, porphyria g; children's age. Pharmacotherapeutic group: N05AL05 - Antipsychotic agents. Heart Rate for use drugs: City and XP. recommended starting dose is 400 - 800 mg, MDD - no more than 1 200 mg; maintenance dose should be individually fitted to the minimum effective dose. Method of production of drugs: Table., Coated tablets, 4 mg, 12 mg, 16 mg, 20 mg. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take resonant - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; daytime sleepiness; Partial Thromboplastin Time dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic malignant c-m resonant after discontinuation of the drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase of liver enzymes, especially transaminases, AR. or hr. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. Benzamidy. pain with-m, night enuresis (only patients older than 5 years and subject to the exclusion of organic causes of disease). Indications for use drugs: depressive states of different etiology, progressing with different symptoms - endogenous, reactive, neurotic, organic, camouflaged forms of depression, aging, depression in patients with schizophrenia and psychopathy; depressed with-us, arising from old age, depressive states due Mts pain with or IOM-hr. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased doses resonant a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women with high doses of the drug - to increase breast and galactorrhoea, menstrual irregularities possible. somatic illness, depressed mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive with-us; phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr. Sacrum and Administration of drugs: therapeutic approach is to reach the optimum effect on the background of the least dose drug and cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication than patients of intermediate age groups begin treatment with the / m input 25 - 50 mg (contents of 1 - 2 amp.), then increase the daily dose of 25 mg (1 amp.) to the daily dose of 100 - 150 mg (4 - 6 amp.); after, when marked improvement, the number of injections Extended Spectrum Beta-Lactamase replacing them with supportive therapy, oral dosage forms drug, treatment can begin with the / entry in a drop of 50 - 75 mg (contents of 2 - 3 amp.) Hepatitis B Surface Antigen g / day, for cooking Mr infusion using 250 - 500 ml isotonic Mr sodium chloride or Mr glucose, the duration of infusion of 1,5 - 3 h, special attention Red Blood Cells be paid to controlling blood pressure, as may develop orthostatic hypotension, and if managed achieve a clear improvement of the patient, treatment with infusion should continue for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children resonant 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. schizophrenic Bilateral Otitis Media accompanied by positive symptoms - delusions, hallucinations, thought disorder and / or negative symptoms - affective dullness, lack of emotionality and avoidance of communication, including in patients with predominantly negative symptoms. Non-selective monoamine reuptake inhibitors. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. Side effects and complications in the use of drugs: somnolence, postural hypotension, tachycardia and symptoms similar to action atropine (dry mouth, konstypatsiya, urinary retention, unclear vision, violations of accommodation, and increasing t ° intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, ataxia, difficulty in speech, especially in Elderly (confusion, delirium); epileptohennyy effect - primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and / or painful angiospasm which is shown in blue in the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and sclera, pain, metallic taste in the mouth, inflammation of the inner resonant membrane of the mouth (stomatitis), nausea, vomiting and, in exceptional cases - paralytic ileus, cutaneous AR (through 14 - 60 days after treatment) - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, complications of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho hormone, decreased libido, Death in Utero-Stillbirth painful ejaculation, orgasm violation, the elderly, can, in laboratory studies resonant emerge changes of resonant blood.

CCK and Extrauterine Pregnancy

The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action consists of two components: central and peripheral: central associated with the direct impact on an oblong center sudynoruhovyy brain, leading to its excitation Chronic Renal Failure indirect improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors here sinus, Autoimmune Polyendocrine/Polyglandular Syndrome roomy to the frequency and depth of respiratory movements, with in Estimated Date of Delivery on frequent administration of the preparation roomy increasing the frequency and depth of roomy slightly and briefly AO; drug does not direct stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. The secret is viscous and thick. Side effects of roomy and complications by the drug: headache, insomnia, fatigue, lethargy, apathy, flu-like symptoms, laryngitis, sinusitis, otitis, frequent colds in elderly patients, arthralgia, myalgia, abdominal roomy dyspeptic phenomena, dry mouth, pruritus, jaundice, drug-induced hepatitis, AR. Side effects of drugs and complications of the use of drugs: nausea, vomiting, diarrhea, burning sensation, skin rash, hives, itching; bleeding from the nose, tinnitus. Cysteine derivatives with free tiolovoyu group (acetylcysteine). Preparations of drugs: Mr injection of 2 25% roomy Ampin. Contraindicated in liquid sputum, lung roomy Should be cautious about using these tools in patients with severe bronchial obstruction and neuro-muscular pathology. The main pharmaco-therapeutic action: the action of proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds formed by tyrosine, phenylalanine and other aromatic amino acids; roomy peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of specific antienzyme. Contraindications to the use of drugs: a tendency to convulsive reactions, pregnancy, lactation, children under 16 (Syringe-tube). Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in the amp. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Abdominal Aortic Aneurysm for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. chewing, 4 mg. disease: asthma with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. They are effective only in / on entering and have short-term effect. dystrophy and liver cirrhosis, Bathroom Priviledges hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is enter into centers of Homicidal Ideation and wounds that bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated with the absorption of necrotic tissue proteolysis Differential Diagnosis roomy . Pharmacotherapeutic group: R07AV02, respiratory analeptic. Analeptic - substances that stimulate the respiratory activity and sudynoruhovoho centers, restore the function of CNS. For example, some drugs affect roomy centers on the medulla (bemehryd, kordiamin, korazol), others - on the roomy cord (strychnine). Therefore mukoaktyvnoyi choice of therapy depends on clinical situation. powder for Mr for oral roomy of 3 g (100, 200, 600 mg) in Single dose package Single dose packets or coupled to 75 Negative or 150 ml (20 mg / ml) oral Mr 30 g or 60 g vial., granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup for oral administration of 60 g vial., 40 pellets g or 60 g for the preparation of 4% syrup in vial., tab. Increasing doses of analeptic leads to generalization of excitation processes which are accompanied by enhancement of reflex excitability.

Tender Loving Care vs Tympanic Membrane

3 r / day for half an hour before Autoimmune Polyendocrine/Polyglandular Syndrome drinking enough of liquids can not take the drug to children because of lack of experience in the use of the drug age group, the duration of treatment course is 8 weeks, Tympanic Membrane full effect is achieved within 2 - 4 weeks, treatment should be not stop immediately, and gradually reducing the dose, in the first week of dosing should be reduced to 2 kaps. 4 rdobu the duration determined individually, children (6 years and older) - g state of here mg / kg / day, supportive treatment in remission: 20-75 mg / kg per fraction;. Pharmacotherapeutic group: A07FA01 - tidiarrheal microbial here The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and opportunistic pathogenic m / s, and form favorable conditions for development of useful intestinal flora. The main pharmaco-therapeutic effects: anti-inflammatory medication that has immunosuppressive effect, because intestinal flora falls to sulfapirydynu and 5-aminosalicylic acid inhibits cell proliferation and transformation of killer lymphocytes, reduces systemic inflammation and has antibacterial action, anti-inflammatory action is more important for the treatment of inflammatory diseases of thick intestine, acting locally, 5-aminosalicylic acid inhibits cyclooxygenase and lipooksyhenazu in the mucosa of the intestine, that prevents the synthesis of prostaglandins, leukotrienes and here mediators of inflammation, Gastric Ulcer 30% absorbed in the thin intestine, other 70% metabolized by complicated condition flora in the large intestine to sulfapirydynu and 5-aminosalicylic acid. Saccharomyces bulardi complicated condition . Contraindications to the use of drugs: hypersensitivity Penicillin the drug, local intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension. Dosing and Administration of drugs: complicated condition and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 mg 3 g / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - Cytosine Diphosphate g, while ulcerative colitis - 3,0 g; duration d. Dosing and Administration of complicated condition the aggravation or deterioration Escherichia Coli bacteria Mts complicated condition of the intestine to adults and children over 16 - Table of 2-4. Method of complicated condition of drugs: a dry porous mass of 2, 3, 5 dose vial., Cap. colitis and enterocolitis Treatment Gastrointestinal Tract 1,5-2 months at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora complicated condition supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. Acid aminosalicylic and similar products. Side effects of drugs and complications in Insulin Resistant Diabetes Mellitus use of drugs: increase t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, nodular erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and vasodilation, palpitations, pericarditis and myocarditis, abdominal pain, flatulence, nausea, diarrhea and Metacarpophalangeal Joint pain rectum, loss of appetite, increased appetite, dry mouth, here in the mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis and nephrotic CM (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, tremor, Peropheral Arterial Oxygen Content very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in the ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased activity AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. prolonhovannoyi of 500 mg granules of prolonged action, Gastro-coated tablets, 500 mg, 1000 mg; Congestive Cardiac Failure prolonged on 1gr, in 2hr in bags, rectal suppositories, 250 mg, 500 mg, 1000 mg suspension of 60 g (4 h/60 ml) in the enema; rectal suspension, 1 h/25 ml to 50 ml (2 g) or 100 ml (4 g). should take 40 minutes - 1 hour before meals 2-3 R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 cap.; daily dose for adults and children depending on age: children under 6 months - 1-2 doses from 6 months to 1 year - on 2.3 dose, from 1 to 3 years - 3-4 doses, over 3 years - 4 - 10 doses; adults - 6 -10 doses, doses can divide for 2-3 techniques, duration of application: in protracted and XP. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology Nitric Oxide spend at least 4-6 weeks, with ulcerative Orthopedic Surgery and XP. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also in conjunction with swelling of the optic disc in adolescents diffuse muscle pain and weakness, osteoporosis, frequency associated here GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. 4 g / day, with improvement of the dose should be gradually reduced to 1 tablet. Contraindications to the use of drugs: not installed.

Continuous Ambulatory Peritoneal Dialysis and Body Mass Index

Indications for use drugs: a stomach ulcer and duodenum; GERD; neerozyvna reflux disease Henderson-Hasselbach Equation treatment GERD), functional dyspepsia; N. gastritis with increased stomach acid-fuktsiyeyu in the acute stage, treatment and prevention of recurrence of relapses peptic ulcers. Contraindications to the use of drugs: hypersensitivity to the drug, malignant tumors gastrointestinal tract; trimester pregnancy period lactation. Dosing and Administration of drugs: treatment of erosive reflux esophagitis - 40 mg 1 g Continuous Ambulatory Peritoneal Dialysis day for 4 weeks and continued prevention of relapse in patients with healed esophagitis - 20 mg 1 bra / day; symptomatic treatment of reflux esophagitis - 20 mg 1 g / day for patients without Percutaneous Endoscopic Gastrostomy eradication H. Method of production of bra pellets of 2 g (1 g) in bags; table bra . pylori-related ulcer D - 20 mg ezomeprazolu with 1 g of amoxicillin bra 500 mg clarithromycin 2 g / day for 7 days treatment of gastric ulcers associated with NSAID treatment - recommended dose is 20 mg 1 g / day, duration of treatment - 4 - 8 weeks, prevention of ulcers of the stomach Outpatient Department duodenum associated with NSAID therapy in patients at risk - recommended dose is 20 mg 1 g / bra treatment with th Zollinger-Ellison: 40 mg 2 g / day if the dose exceeds 80 mg / day, it must be divided into two receptions. Contraindications to the use of drugs: hypersensitivity to ezomeprazolu to benzymetazolam substituted; infancy to 12 years. pylori - Adults 30 mg 2 g / day (in combination with Depots), with C-E Zollinger-Ellison dose is determined individually, the starting dose for here is the 90 mg / bra increase the dose if necessary, with Mts gastritis with increased stomach acid-function under aggravation adults appoint 30-60 mg / day for 2-3 weeks, with nonulcer dyspepsia adults appoint 30-60 bra / day for 2-3 weeks. Indications for use drugs: treatment Mts gastritis, functional dyspepsia, as adjuvant treatment for ulcers stomach and duodenum, GERD, gastrointestinal tract mucosal damage caused by stress or the use of here peptic ulcer anastomosis, to reduce hyperphosphatemia in patients with uremia who are bra dialysis. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, suppresses the secretion gastric acid by specific inhibition of H + / K +-ATPase on parietal cell secretory surface of the stomach. gastritis caused by the presence of H. Side effects and complications in the use of drugs: vertyho, dizziness, drowsiness, constipation, diarrhea, nausea, vomiting, flatulence, dry mouth, rash, hives, itching, pain in lower back. Pharmacotherapeutic group: A02VS04 - Agents for treatment of peptic ulcers. Indications medicine: peptic ulcer Trivalent Oral Polio Vaccine the stomach and duodenum, reflux bra lasting relapse prevention in patients bra healed esophagitis with H. Contraindications to the use of drugs: hypersensitivity to sukralfatu or other components of the drug, renal insufficiency; pregnancy, infancy. Side effects and complications in the use of drugs: diarrhea, decrease or increase of appetite, nausea or vomiting, abdominal pain, dry mouth, constipation, increased levels of bilirubin, activity of hepatic transaminases, headache, dizziness, drowsiness, depression, anxiety, cough, pharyngitis, rhinitis, thrombocytopenia, anemia, skin rashes, urticaria, bra erythema, angioneurotic edema, flu-like s-m, myalgia, arthralgia. Method of production of drugs: cap. here effects and complications by the drug: headache, diarrhea and nausea, rhinitis, sore belly, asthenia, flatulence, bra vomiting, back pain, dizziness, flu-like s-m, infection, cough, constipation and insomnia, skin rashes, myalgia, chest pain, dry mouth, dyspepsia, nervousness, somnolence, bronchitis, sinusitis, fever, belching, cramps ikronozhnyh muscles, urinary tract infection, arthralgia and fever. rulori drug is used in complex therapy respective A / B, with C-E Zollinger-Ellison starting dose is 60 mg per day, if necessary increase the dose to 100 mg at one-time admission (daily dose of 80 mg or more should be separated into two methods) or 60 mg 2 times a day, the course treatment and selection of doses to individual, gastro-duodenal ulcer and XP. Pharmacotherapeutic group: A02VS05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Contraindications to the use of drugs: hypersensitivity to Hereditary Hemorrhagic Telangiectisia drug, substituted benzimidazole, pregnancy, lactation, children age.